Who owns Biotônico Fontoura?
Biotônico Fontoura is owned by Hypera (Brazil, B3: HYPE3).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Key facts
- Current owner
- Hypera Pharma reported
- Owned since
- Not recorded
- Previous owner
- None recorded
- Owner HQ
- 🇧🇷 Brazil, São Paulo
- Origin
- 🇧🇷 Brazil
- Category
- Food › Nutrition & supplements › Vitamins & supplements
- Parent ticker
- B3: HYPE3
- Last verified
- · 1 sources
About Biotônico Fontoura
Biotônico Fontoura is an iron supplement syrup sold by Hypera Pharma in 400 ml bottles in original, strawberry and grape flavours. Hypera markets it with the line that it strengthens what matters most, your family, and places it in its consumer health nutritionals and vitamin supplements segment, alongside Tamarine and Zero-Cal.
Ownership timeline of Biotônico Fontoura
Where Biotônico Fontoura sits in Hypera
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Hypera ownership tree →
Other brands owned by Hypera
Latest news about Biotônico Fontoura
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Biotônico Fontoura?
The parent company of Biotônico Fontoura is Hypera, a publicly listed company headquartered in Brazil.
Is Biotônico Fontoura Brazilian?
Yes. Biotônico Fontoura originated in Brazil and its owner, Hypera, is also headquartered in Brazil.
Is Biotônico Fontoura still owned by Hypera?
Yes. As of 16 September 2026, Biotônico Fontoura is still owned by Hypera. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.